About: Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease. The company is based in Bala Cynwyd, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.87 (-5.03%)
LRMRNASDAQLarimar Therapeutics Inc
Loading watchlist status…
Larimar Therapeutics Inc share price
LRMR price activity
Last Price
$3.870
Change (24hr)
-0.21 USD (-5.03%)
Volume
976.68K
Volume (4w avg)
-
Open
$4.03
Day Range
$3.83 - $4.16
Previous Close
$4.08
Last Trade
09 Sep, 8:00 pm GMT+0
Delayed
09 Sep, 8:00 pm GMT+0
LRMR price performance
0%
5D
-6.97%
1M
1.57%
YTD
0%
1Y
Delayed
09 Sep, 8:00 pm GMT+0
LRMR Market Signals